Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 29 | 2020 | 203 | 10.510 |
Why?
|
| Stroke | 15 | 2022 | 233 | 5.950 |
Why?
|
| Cerebral Hemorrhage | 9 | 2023 | 90 | 3.520 |
Why?
|
| Ischemic Attack, Transient | 7 | 2020 | 25 | 3.120 |
Why?
|
| Platelet Count | 11 | 2019 | 112 | 2.810 |
Why?
|
| Platelet Activation | 9 | 2019 | 54 | 2.670 |
Why?
|
| Cognition Disorders | 8 | 2019 | 181 | 2.450 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 2022 | 54 | 2.210 |
Why?
|
| Copper | 8 | 2011 | 44 | 2.090 |
Why?
|
| Aged | 40 | 2024 | 5166 | 1.960 |
Why?
|
| Cognitive Dysfunction | 8 | 2024 | 259 | 1.830 |
Why?
|
| Middle Aged | 41 | 2024 | 6820 | 1.830 |
Why?
|
| Brain Ischemia | 5 | 2020 | 80 | 1.730 |
Why?
|
| Male | 52 | 2024 | 12875 | 1.710 |
Why?
|
| Brain Infarction | 4 | 2015 | 10 | 1.700 |
Why?
|
| Alzheimer Disease | 8 | 2021 | 210 | 1.690 |
Why?
|
| Blood Coagulation | 4 | 2019 | 116 | 1.590 |
Why?
|
| Veterans | 3 | 2019 | 66 | 1.520 |
Why?
|
| Humans | 73 | 2024 | 26846 | 1.500 |
Why?
|
| Female | 48 | 2024 | 14463 | 1.500 |
Why?
|
| Carotid Stenosis | 3 | 2014 | 24 | 1.410 |
Why?
|
| Facial Expression | 5 | 2013 | 16 | 1.270 |
Why?
|
| Aged, 80 and over | 18 | 2019 | 1926 | 1.270 |
Why?
|
| Risk Factors | 16 | 2020 | 2010 | 1.230 |
Why?
|
| Emotions | 5 | 2013 | 131 | 1.090 |
Why?
|
| Cognition | 5 | 2019 | 294 | 1.060 |
Why?
|
| Hypertension | 6 | 2023 | 304 | 1.050 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2020 | 187 | 1.010 |
Why?
|
| Functional Laterality | 4 | 2013 | 62 | 1.000 |
Why?
|
| Adult | 19 | 2019 | 7384 | 0.900 |
Why?
|
| Serotonin Uptake Inhibitors | 4 | 2019 | 26 | 0.870 |
Why?
|
| Dementia | 4 | 2023 | 87 | 0.810 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2011 | 30 | 0.780 |
Why?
|
| Dementia, Vascular | 2 | 2019 | 51 | 0.780 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2019 | 58 | 0.760 |
Why?
|
| Pilot Projects | 9 | 2022 | 390 | 0.730 |
Why?
|
| Vitamin B 12 Deficiency | 3 | 2009 | 9 | 0.700 |
Why?
|
| Pattern Recognition, Visual | 3 | 2013 | 37 | 0.700 |
Why?
|
| Stroke, Lacunar | 1 | 2020 | 3 | 0.690 |
Why?
|
| Thrombin | 7 | 2017 | 68 | 0.670 |
Why?
|
| Intracranial Embolism | 1 | 2019 | 6 | 0.670 |
Why?
|
| Amnesia | 2 | 2011 | 9 | 0.660 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 446 | 0.650 |
Why?
|
| Aneurysm | 1 | 2019 | 25 | 0.640 |
Why?
|
| Cerebrovascular Circulation | 2 | 2019 | 211 | 0.640 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 472 | 0.640 |
Why?
|
| Valsalva Maneuver | 1 | 2018 | 8 | 0.630 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 133 | 0.630 |
Why?
|
| Lymphocytes | 1 | 2019 | 83 | 0.630 |
Why?
|
| Collagen | 6 | 2017 | 147 | 0.580 |
Why?
|
| Time Factors | 6 | 2019 | 1563 | 0.550 |
Why?
|
| Microcirculation | 1 | 2017 | 111 | 0.540 |
Why?
|
| Microvessels | 1 | 2017 | 85 | 0.540 |
Why?
|
| Platelet Transfusion | 1 | 2016 | 29 | 0.530 |
Why?
|
| Face | 2 | 2013 | 25 | 0.520 |
Why?
|
| Smoking | 4 | 2019 | 466 | 0.510 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 30 | 0.510 |
Why?
|
| Brain Concussion | 1 | 2015 | 43 | 0.500 |
Why?
|
| Spinal Cord Diseases | 2 | 2006 | 30 | 0.490 |
Why?
|
| Carotid Artery, Internal | 1 | 2014 | 19 | 0.470 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 17 | 0.470 |
Why?
|
| Activities of Daily Living | 2 | 2015 | 100 | 0.470 |
Why?
|
| Indians, North American | 1 | 2019 | 511 | 0.470 |
Why?
|
| Brain Injuries | 1 | 2014 | 49 | 0.460 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 37 | 0.460 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 57 | 0.460 |
Why?
|
| Medication Adherence | 1 | 2014 | 46 | 0.450 |
Why?
|
| Smoking Cessation | 1 | 2019 | 398 | 0.450 |
Why?
|
| Visual Fields | 1 | 2013 | 31 | 0.450 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 910 | 0.440 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 105 | 0.440 |
Why?
|
| Social Perception | 1 | 2013 | 23 | 0.440 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2023 | 802 | 0.430 |
Why?
|
| Zinc | 3 | 2004 | 57 | 0.420 |
Why?
|
| Aspirin | 2 | 2019 | 119 | 0.420 |
Why?
|
| Attention | 1 | 2013 | 90 | 0.420 |
Why?
|
| Enteric Nervous System | 1 | 2011 | 10 | 0.400 |
Why?
|
| Demyelinating Diseases | 2 | 2002 | 4 | 0.390 |
Why?
|
| Diabetes Complications | 2 | 2019 | 66 | 0.380 |
Why?
|
| Ceruloplasmin | 2 | 2009 | 8 | 0.370 |
Why?
|
| Risk Assessment | 3 | 2019 | 586 | 0.370 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 39 | 0.370 |
Why?
|
| Intestines | 1 | 2011 | 117 | 0.360 |
Why?
|
| Prospective Studies | 5 | 2023 | 1216 | 0.360 |
Why?
|
| Platelet Function Tests | 3 | 2015 | 24 | 0.350 |
Why?
|
| Cerebral Infarction | 1 | 2010 | 26 | 0.350 |
Why?
|
| Sertraline | 1 | 2009 | 5 | 0.350 |
Why?
|
| Aphasia | 1 | 2009 | 5 | 0.340 |
Why?
|
| Recurrence | 3 | 2020 | 316 | 0.340 |
Why?
|
| Frontotemporal Dementia | 1 | 2009 | 4 | 0.330 |
Why?
|
| Disease Progression | 5 | 2023 | 450 | 0.330 |
Why?
|
| Mental Status and Dementia Tests | 2 | 2019 | 14 | 0.330 |
Why?
|
| Gastrectomy | 1 | 2009 | 19 | 0.320 |
Why?
|
| Case-Control Studies | 5 | 2015 | 702 | 0.320 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2008 | 2 | 0.310 |
Why?
|
| Myelin Proteins | 1 | 2008 | 13 | 0.310 |
Why?
|
| Prognosis | 3 | 2017 | 759 | 0.310 |
Why?
|
| Point Mutation | 1 | 2008 | 60 | 0.310 |
Why?
|
| Regression Analysis | 2 | 2019 | 209 | 0.300 |
Why?
|
| Neurodegenerative Diseases | 2 | 2007 | 21 | 0.300 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2022 | 216 | 0.300 |
Why?
|
| Blood Coagulation Factors | 1 | 2008 | 31 | 0.300 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 72 | 0.280 |
Why?
|
| Referral and Consultation | 1 | 2007 | 87 | 0.280 |
Why?
|
| Budesonide | 1 | 2006 | 2 | 0.280 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2006 | 2 | 0.280 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 980 | 0.270 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2015 | 26 | 0.260 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2003 | 28 | 0.260 |
Why?
|
| Aging | 2 | 2017 | 945 | 0.250 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 508 | 0.230 |
Why?
|
| Public Health | 2 | 2022 | 84 | 0.230 |
Why?
|
| Postoperative Complications | 1 | 2009 | 604 | 0.230 |
Why?
|
| Diabetic Neuropathies | 1 | 2004 | 14 | 0.230 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2004 | 17 | 0.230 |
Why?
|
| Pandemics | 2 | 2023 | 166 | 0.230 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 203 | 0.230 |
Why?
|
| Cohort Studies | 2 | 2017 | 859 | 0.220 |
Why?
|
| Basilar Artery | 1 | 2003 | 7 | 0.220 |
Why?
|
| Trigeminal Neuralgia | 1 | 2003 | 12 | 0.220 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2023 | 14 | 0.220 |
Why?
|
| Odds Ratio | 2 | 2015 | 231 | 0.210 |
Why?
|
| Young Adult | 3 | 2019 | 2582 | 0.210 |
Why?
|
| Age Factors | 3 | 2019 | 716 | 0.210 |
Why?
|
| Migraine with Aura | 1 | 2002 | 2 | 0.210 |
Why?
|
| Neurovascular Coupling | 1 | 2024 | 152 | 0.200 |
Why?
|
| White Matter | 1 | 2023 | 89 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 465 | 0.200 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 144 | 0.200 |
Why?
|
| Dominance, Cerebral | 1 | 2001 | 10 | 0.200 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 400 | 0.190 |
Why?
|
| Prevalence | 2 | 2022 | 472 | 0.190 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 86 | 0.190 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2020 | 7 | 0.190 |
Why?
|
| Neuropsychological Tests | 3 | 2023 | 237 | 0.180 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 48 | 0.180 |
Why?
|
| Retrospective Studies | 3 | 2022 | 2432 | 0.180 |
Why?
|
| Central Nervous System Diseases | 1 | 2000 | 12 | 0.180 |
Why?
|
| Scalp | 1 | 2000 | 13 | 0.180 |
Why?
|
| United States | 3 | 2015 | 2031 | 0.170 |
Why?
|
| Flow Cytometry | 2 | 2014 | 282 | 0.170 |
Why?
|
| Mean Platelet Volume | 1 | 2019 | 4 | 0.160 |
Why?
|
| Incidence | 2 | 2012 | 545 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2009 | 93 | 0.160 |
Why?
|
| Cerebral Veins | 1 | 2019 | 11 | 0.160 |
Why?
|
| Cognitive Aging | 1 | 2019 | 21 | 0.160 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 36 | 0.160 |
Why?
|
| Warfarin | 1 | 2019 | 94 | 0.160 |
Why?
|
| Swimming | 1 | 2018 | 31 | 0.160 |
Why?
|
| Skin Neoplasms | 1 | 2000 | 128 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 152 | 0.150 |
Why?
|
| Treatment Outcome | 2 | 2019 | 2264 | 0.150 |
Why?
|
| Vascular Remodeling | 1 | 2017 | 14 | 0.140 |
Why?
|
| Matrix Metalloproteinases | 1 | 2017 | 31 | 0.140 |
Why?
|
| Surface Properties | 2 | 2008 | 132 | 0.140 |
Why?
|
| Memory | 1 | 2017 | 71 | 0.140 |
Why?
|
| Memory Disorders | 1 | 2017 | 47 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 111 | 0.130 |
Why?
|
| Hemodynamics | 1 | 2017 | 220 | 0.130 |
Why?
|
| Patient Admission | 1 | 2015 | 28 | 0.130 |
Why?
|
| Biomarkers | 1 | 2019 | 733 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 278 | 0.120 |
Why?
|
| Mortality | 1 | 2015 | 43 | 0.120 |
Why?
|
| Personal Satisfaction | 1 | 2015 | 27 | 0.120 |
Why?
|
| Hematologic Tests | 1 | 2014 | 7 | 0.120 |
Why?
|
| Inflammation | 1 | 2019 | 601 | 0.120 |
Why?
|
| Logistic Models | 1 | 2015 | 397 | 0.120 |
Why?
|
| Reference Values | 2 | 2007 | 198 | 0.120 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 37 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 213 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 189 | 0.110 |
Why?
|
| Deficiency Diseases | 2 | 2006 | 6 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2007 | 388 | 0.110 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 34 | 0.110 |
Why?
|
| Animals | 3 | 2019 | 9962 | 0.110 |
Why?
|
| Brain | 3 | 2023 | 699 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 35 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 2011 | 40 | 0.100 |
Why?
|
| Biological Transport | 1 | 2011 | 111 | 0.100 |
Why?
|
| Eating | 1 | 2011 | 66 | 0.100 |
Why?
|
| Platelet Adhesiveness | 1 | 2011 | 6 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2012 | 263 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2011 | 253 | 0.090 |
Why?
|
| Body Weight | 1 | 2011 | 246 | 0.090 |
Why?
|
| Muscle Contraction | 1 | 2011 | 162 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 545 | 0.090 |
Why?
|
| Psychomotor Agitation | 1 | 2009 | 7 | 0.090 |
Why?
|
| Hostility | 1 | 2009 | 3 | 0.090 |
Why?
|
| Hyperhomocysteinemia | 1 | 2009 | 28 | 0.080 |
Why?
|
| Risk | 1 | 2009 | 133 | 0.080 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2008 | 3 | 0.080 |
Why?
|
| Family Health | 1 | 2008 | 71 | 0.080 |
Why?
|
| Pedigree | 1 | 2008 | 153 | 0.080 |
Why?
|
| Rats | 1 | 2011 | 1545 | 0.080 |
Why?
|
| Drug Utilization | 1 | 2008 | 28 | 0.080 |
Why?
|
| Vitamin B 12 | 1 | 2007 | 6 | 0.070 |
Why?
|
| Mental Status Schedule | 1 | 2007 | 9 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2009 | 213 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 80 | 0.070 |
Why?
|
| Comorbidity | 1 | 2008 | 252 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2006 | 25 | 0.070 |
Why?
|
| Interpersonal Relations | 1 | 2007 | 64 | 0.070 |
Why?
|
| Crotalid Venoms | 1 | 2006 | 4 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2006 | 118 | 0.060 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 36 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 110 | 0.060 |
Why?
|
| Communication | 1 | 2007 | 167 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2008 | 1090 | 0.060 |
Why?
|
| Polyneuropathies | 1 | 2004 | 3 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2024 | 72 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2006 | 503 | 0.060 |
Why?
|
| Neutropenia | 1 | 2004 | 35 | 0.060 |
Why?
|
| Diabetic Foot | 1 | 2004 | 17 | 0.060 |
Why?
|
| Anemia | 1 | 2004 | 41 | 0.060 |
Why?
|
| Glucose Tolerance Test | 1 | 2004 | 57 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2004 | 28 | 0.060 |
Why?
|
| Dilatation, Pathologic | 1 | 2003 | 11 | 0.060 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 53 | 0.050 |
Why?
|
| Coma | 1 | 2002 | 4 | 0.050 |
Why?
|
| Paresis | 1 | 2002 | 5 | 0.050 |
Why?
|
| Vasospasm, Intracranial | 1 | 2002 | 14 | 0.050 |
Why?
|
| Support Vector Machine | 1 | 2022 | 21 | 0.050 |
Why?
|
| ADAMTS13 Protein | 1 | 2022 | 126 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2024 | 305 | 0.050 |
Why?
|
| Radiography | 1 | 2002 | 200 | 0.050 |
Why?
|
| ROC Curve | 1 | 2022 | 139 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 207 | 0.050 |
Why?
|
| Anemia, Sideroblastic | 1 | 2000 | 2 | 0.040 |
Why?
|
| Necrosis | 1 | 2000 | 81 | 0.040 |
Why?
|
| Exercise Test | 1 | 2020 | 246 | 0.040 |
Why?
|
| Pregnancy | 1 | 2020 | 1130 | 0.030 |
Why?
|
| Child | 1 | 2002 | 2146 | 0.030 |
Why?
|
| Role | 1 | 2015 | 5 | 0.030 |
Why?
|
| Prosencephalon | 1 | 2007 | 7 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2007 | 117 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2006 | 22 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2006 | 50 | 0.020 |
Why?
|
| Forecasting | 1 | 2006 | 71 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2006 | 250 | 0.020 |
Why?
|
| Oklahoma | 1 | 2006 | 973 | 0.010 |
Why?
|